Felix Theeuwes
2006
In 2006, Felix Theeuwes earned a total compensation of $1M as Chairman and Chief Scientific Officer at DURECT.
Compensation breakdown
Non-Equity Incentive Plan | $150,698 |
---|---|
Option Awards | $423,190 |
Salary | $425,250 |
Other | $11,293 |
Total | $1,010,431 |
Theeuwes received $425.3K in salary, accounting for 42% of the total pay in 2006.
Theeuwes also received $150.7K in non-equity incentive plan, $423.2K in option awards and $11.3K in other compensation.
Rankings
In 2006, Felix Theeuwes' compensation ranked 3,052nd out of 7,022 executives tracked by ExecPay. In other words, Theeuwes earned more than 56.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,052 out of 7,022 | 57th |
Division Manufacturing | 969 out of 2,413 | 60th |
Major group Chemicals And Allied Products | 210 out of 673 | 69th |
Industry group Drugs | 129 out of 518 | 75th |
Industry Pharmaceutical Preparations | 104 out of 355 | 71st |
Source: SEC filing on April 29, 2009.
Theeuwes' colleagues
We found six more compensation records of executives who worked with Felix Theeuwes at DURECT in 2006.
2006
James Brown
DURECT
Chief Executive Officer
2006
Su Yum
DURECT
Executive Vice President, Pharmaceutical Systems R&D
2006
Jean Liu
DURECT
General Counsel
2006
Jian Li
DURECT
Vice President of Finance and Corporate Controller
2006
Peter Langecker
DURECT
Chief Medical Officer
2006
Matthew Hogan
DURECT